Vialwirebiotech, curated
October 1, 2026, 1:17 PM
July 23, 2026
- 12:23 PM · STAT News12:23 PMSTAT+: Popular insulin product enters shortage as other pens leave market — STAT News
- 12:00 PM · BioWorld12:00 PMDrug companies lose appeal on 340B rebates — BioWorld
- 11:13 AM · Bloomberg — Technology11:13 AMThermo Fisher Rises as Instrument Demand Recovery Lifts Outlook — Bloomberg — Technology
- 9:07 AM · Drug Discovery World9:07 AMPhase I/II trial will assess sarcoma metastatic recurrence prevention — Drug Discovery World
- 9:00 AM · BioWorld9:00 AMInsilico Medicine nominates ISM-9528 as candidate analgesic — BioWorld
- 9:00 AM · BioWorld9:00 AMMentari Therapeutics raises funds to support migraine pipeline — BioWorld
- 9:00 AM · BioWorld9:00 AMEvogene and Eleo collaborate to discover PCSK9 pathway inhibitors — BioWorld
- 9:00 AM · BioWorld9:00 AMSeries A financing at Tikva Allocell to advance TAVST-01 — BioWorld
- 9:00 AM · BioWorld9:00 AMAbera seeks clinical trial clearance for AB-01.12 — BioWorld
- 6:00 AM · Pharmaceutical Executive6:00 AM<![CDATA[GLP-1’s Cardiometabolic Benefit and the Impact on Coverage]]> — Pharmaceutical Executive
- 5:39 AM · Pharmaceutical Technology5:39 AMAffinia Therapeutics receives FDA orphan drug designation for AFTX-201 — Pharmaceutical Technology
- 5:00 AM · Drug Discovery World5:00 AMRege Nephro secures US$10.6m for ADPKD and beyond — Drug Discovery World
- 4:47 AM · Pharmaceutical Technology4:47 AMCrystalys banks $130m to progress gout drug, plan for commercial readiness — Pharmaceutical Technology
- 1:01 AM · Bloomberg — Technology1:01 AMDassault Systèmes to Buy Drug Trial Software Firm ArisGlobal — Bloomberg — Technology
July 22, 2026
- 5:11 PM · BioWorld5:11 PMGSK’s newly acquired Jideytro wins FDA nod in NSCLC — BioWorld
- 4:48 PM · BioPharma Dive4:48 PMVertex was sole bidder in high-premium Crinetics acquisition — BioPharma Dive
- 12:00 PM · BioWorld12:00 PMUS Senate greenlights bill to tame biologic patent thickets — BioWorld
- 12:00 PM · BioWorld12:00 PMArrowhead rises on phase III hypertriglyceridemia readout — BioWorld
- 12:00 PM · BioWorld12:00 PMDrum KIT: Celldex CSU rhythm still on post-barzo PN phase II — BioWorld
- 10:50 AM · Pharmaceutical Technology10:50 AMSpeciality versus diversity: the four-way CDMO race in outsourced HPAPI manufacturing — Pharmaceutical Technology
- 10:12 AM · Pharmaceutical Technology10:12 AMSamsung Biologics: geographic diversification is a sound business decision — Pharmaceutical Technology
- 9:00 AM · BioWorld9:00 AMFinancing at Immitra Bio to advance in vivo gene editing therapies — BioWorld
- 9:00 AM · BioWorld9:00 AMPharmability’s TIR-C gains trial clearance for atopic dermatitis — BioWorld
- 9:00 AM · BioWorld9:00 AMVerismo unveils CLDN6-targeting KIR-CAR program — BioWorld
- 9:00 AM · BioWorld9:00 AMEstrigenix Therapeutics raises financing to advance ERβ platform — BioWorld
- 5:50 AM · Bloomberg — Technology5:50 AMRetina Chip Designed to Restore Sight to Go on Sale in Europe — Bloomberg — Technology
- 5:41 AM · Pharmaceutical Technology5:41 AMKyowa Kirin EMEA’s Crysvita approved by EC for infants with XLH — Pharmaceutical Technology
- 4:49 AM · Pharmaceutical Technology4:49 AMCellares and Papillon partner for PPL-001 manufacturing automation — Pharmaceutical Technology
July 21, 2026
- 9:27 PM · TechCrunch
- 8:44 PM · FT — Pharmaceuticals8:44 PMTrump plans 100% tariffs on generic drugs in 2028 — FT — Pharmaceuticals
- 7:00 PM · SCMP — Tech7:00 PMWhat’s at stake as Beijing beats global peers with first approval of novel therapy — SCMP — Tech